Questions for Baxter

QUESTION TO BAXTER EXECUTIVES

by Alexander S Jones
former employee of NIH
LSBR / NIAMS

You initially claimed “trade secrets” regarding the vaccine contamination. Could you explain why Baxter initially attempted to cover this up?

Despite popular media claims to the contrary, coinfection of H5N1 and H3N2 would not produce simple reassortment. It would produce complex in vivo recombination of many competing strains in the infected host. Does Baxter agree with this assessment?

Furthermore the complex coinfection of H5N1 and H3N2 in a human would produce natural selection pressure for maximum virulence. Does Baxter dispute this claim? If so, why? If not, please explain why on earth would Baxter attempt to cover up an incident which may well have been lethal to 99% of humanity?

The book “Evolutionary Dynamics” suggest that viral coinfection selects for both maximum virulence and infectivity. Does Baxter dispute these mathematics? Considering this danger is well known among virologists, can Baxter immediately explain the precise sequence of events, including dates, times, and people involved, which led to contamination in over 16 labs in three separate countries in Europe with coinfected H5N1 and H3N2 material?

Is Baxter prepared to cooperate with all relevant authorities in the multiple countries to publicly release the genetic sequences of the contaminated material? Furthermore, what Clade was Baxter’s H5N1 vaccine from? Clade 1? Clade 2? Clade 3? Other? Is part of the reason Baxter is so eager to destroy the existing vaccine material that executives are concerned the world will find out their ‘custom’ H5N1 does not resemble the strains circulating in waterfowl?

Can Baxter please disclose all financial and social connections it has with the incoming Obama administration (as Baxter and its executives are based near Chicago) and whether Baxter stood to benefit financially from the outbreak of a pandemic through a contaminated season influenza vaccine in late 2009? Does Treasury Sec Geithner hold shares in Baxter? If so, how many shares?

Baxter Director Gail Fosler has profoundly disturbing connections to powerful organizations including the Council on Foreign Relations, high-level Chinese CCP leadership, and the Federal Reserve Bank of New York. The question is simple: Is Baxter involved in biological weapons programs? Are any of these programs ‘international’ in scope? If so , who is providing the funding? What is the nature and intent of these programs? Are any of these programs part of the so-called ‘black budget’? That is , is Baxter involved in any “Special Access Programs” , as defined by Congress? Are any of these ‘waived’ “Special Access Programs”? Are any of these ‘unacknowledged’ ‘waived’ Special Access Programs (also known as ‘black programs’)?

Can Baxter explain exactly how a Level 3 biological warfare pathogen found its way into H3N2 material, regardless whether or not this experimental vaccine material was ‘intended’ for eventual use in humans or not. Is the contaminated H5N1 strain genetically engineered? If so, by whom? Does the NS protein in Baxter’s H5N1 material contain polymorphisms which suppress human interferon production? Was Baxter’s H5N1a full set of influenza genes? Or was it just the hemaglutanin and neuraminidase? Did Baxter’s H5N1 contain a poly-basic cleavage site on the Hemaglutanin surface protein? Why were the samples of experimental vaccine material not irradiated?

Are Baxter executives prepared to testify before Congress , under oath, that their corporation is not involved in biological warfare programs?

Baxter’s explanation so far has been chilling to put it mildly. Furthermore, it would be in Baxter’s best interest, if it were not involved in criminal activities, to set the record straight? Does Baxter not agree its silence and weak explanations suggest possible criminal malfeasance? If not criminally involved, why will Baxter executives not provide a complete and full account of this supposed contamination, (if indeed it was contamination rather than intentional weaponization.)

Do Baxter executives have any financial and/or personal connections to Toyama Pharma and T-705, an influenza polymerase inhibitor? Has Baxter experimented with influenza polymerase inhibitors? Will Baxter disclose precisely what its financial positions are regarding H5N1 pandemic ‘therapy’ included its intended market timelines? The ‘contamination’ was an extremely serious breach of risk as Baxter could have easily exterminated most of the human race if this experimental material was made into vaccines.

Why does Baxter hold patents on avian influenza RNA polymerase promoters? What legitimate public health and/or scientific interest does Baxter have in this research? (see Application number: 10/547,155, Publication number: US 2007/0134270 A) Will all Baxter executives come forward and immediately renounce weaponization of biologics? Are Baxter executives concerned about possible civil and/or criminal actions brought against them? Why or why not?

What are the financial connections between the Federal Reserve System and Baxter? Does Baxter receive funding from JP Morgan or Goldman Sachs? Does Baxter receive any national security exemptions (waivers)?

What specific steps , including a precise timeline, does Baxter plan on doing to allay the concerns of both the public and the scientific community? Again, can Baxter please describe the precise nature of their H5N1 strain, including genetic sequences, from where it was obtained, and whether it was genetically engineered? If genetically engineered, what modifications were made? Single nucleotide polymorphisms? RNA Recombination? Reassortment? What exactly, was in this experimental vaccine material? We want scientific answers immediately.